INDEPSO

Official account of the 'Indian Network for DEvelopment of Peritoneal Surface Oncology'

#réinvention #collaboration

[INDEPSO @indepso]

CRS & HIPEC demands more than technical skill.
It demands systems, structure, judgement, and relentless academic rigor.
Honoured to welcome Prof. @LanaBijelicMD
Chief, Peritoneal Surface Malignancies Unit, CHU Moisés Broggi, Barcelona
Academic Coordinator, ESPSO

A global leader helping shape modern Peritoneal Surface Oncology through education and multidisciplinary collaboration.
📍 Pune, India
📅 17–19 September 2026
Register:https://t.co/ZHc2MTeFWr

#CRS #HIPEC #LanaBijelic #PeritonealSurfaceOncology #SurgicalOncology #OGP2026

[INDEPSO @indepso]

When CRS gets difficult, textbooks stop helping.
That’s where surgical judgement begins.
Excited to welcome Prof. @artemstepanyan to the 3rd Biennial Conference of the Oncology Group of Pune.

Known for expertise in complex abdominal oncology and advanced cytoreductive surgery, his work reflects the precision and adaptability modern Peritoneal Surface Oncology demands.

📍 Pune, India
📅 17–19 September 2026

Register:https://t.co/ZHc2MTeFWr

#CRS #HIPEC #ArtemStepanyan #PeritonealSurfaceOncology #SurgicalOncology #OGP2026

[Artem Stepanyan @artemstepanyan]

@indepso Honored to join the international faculty at OGP 2026 in Pune, India.

Looking forward to an inspiring meeting on peritoneal surface oncology, CRS, HIPEC and surgical education.

Thank you INDEPSO/SPSOI and the organizing committee.

[INDEPSO @indepso]

When CRS gets difficult, textbooks stop helping.
That’s where surgical judgement begins.
Excited to welcome Prof. @artemstepanyan to the 3rd Biennial Conference of the Oncology Group of Pune.

Known for expertise in complex abdominal oncology and advanced cytoreductive surgery, his work reflects the precision and adaptability modern Peritoneal Surface Oncology demands.

📍 Pune, India
📅 17–19 September 2026

Register:https://t.co/ZHc2MTeFWr

#CRS #HIPEC #ArtemStepanyan #PeritonealSurfaceOncology #SurgicalOncology #OGP2026

[INDEPSO @indepso]

CRS & HIPEC is easy on slides.
Reality begins when planes disappear, resections get complex, and judgement matters more than theory.
Honoured to welcome Prof. @glehenolivier — one of the global leaders in Peritoneal Surface Oncology — to the 3rd Biennial Conference of the Oncology Group of Pune.
A surgeon whose work has helped define modern standards in CRS, HIPEC, and complex peritonectomy surgery worldwide.
📍 Pune, India
📅 17–19 September 2026
Register here: https://t.co/ZHc2MTeFWr

#CRS #HIPEC #OlivierGlehen #PeritonealSurfaceOncology #SurgicalOncology #OGP2026

[INDEPSO @indepso]

Anyone can quote Sugarbaker scores in a conference hall.
The real test begins when the abdomen is open, the planes are obliterated, the disease is everywhere, and your team still has to deliver a safe, complete cytoreduction.
CRS & HIPEC is not surgical tourism.
It is not “advanced debulking.”
And it definitely isn’t for centres chasing trends without understanding the brutality of the learning curve.

Because this is what the textbooks don’t prepare you for:
▪️ Distorted anatomy
▪️ Endless peritonectomy planes
▪️ Massive resections
▪️ Fluid shifts and physiology under siege
▪️ Team fatigue
▪️ Complications that demand experience, not panic
The difference between average and exceptional outcomes is rarely knowledge alone.
It is operative judgement under pressure.
This workshop is built around the uncomfortable realities of CRS & HIPEC — where theory meets tissue, and where surgical oncology becomes very, very real.

#CRS #HIPEC #PeritonealSurfaceMalignancy #SurgicalOncology #GynecologicOncology #CancerSurgery #OncoSurgery #Peritonectomy #MedicalEducation #CadavericWorkshop
@PSugarbaker @glehenolivier @writeslkpushkin @MufaddalKazi @zeebausofi @vivekanandkem @sukumar_vivek @Bhandoria @Snioncosurgeon1 @docswapnil01

[INDEPSO @indepso]

Speaker Spotlight | Prof. @PSugarbaker

Few names have shaped Peritoneal Surface Oncology the way Prof. Paul Sugarbaker has.
Widely regarded as the pioneer of Cytoreductive Surgery (CRS) and HIPEC, his work transformed what was once considered terminal peritoneal disease into a field of aggressive, biology-driven surgical oncology with meaningful long-term outcomes.
From establishing the principles of peritonectomy to redefining surgical strategies for peritoneal malignancies, generations of surgeons across the world continue to learn from his vision, techniques, and relentless pursuit of oncologic precision.
We are honoured to welcome Prof. Sugarbaker as part of the international faculty at the
3rd Biennial Conference of the Oncology Group of Pune.
Conference Highlights:
▪️ Cadaveric Workshop
▪️ Didactic Lectures & Panel Discussions
▪️ Stellar International & National Faculty
▪️ Live Pathology Workshop
📍 Pune, India
📅 17–19 September 2026
Register now:
OGP 2026 Registration: https://t.co/ZHc2MTeFWr
#CRS #HIPEC #PaulSugarbaker #PeritonealSurfaceOncology #SurgicalOncology #CancerSurgery #GynecologicOncology #OncoSurgery #MedicalTwitter #CadavericWorkshop

[INDEPSO @indepso]

Most surgeons can talk about CRS & HIPEC.
But when the planes disappear, the bowel is hostile, the diaphragm is stuck, the pelvis is frozen, and the clock has crossed hour eight… that’s when surgical oncology stops being academic.
That’s when judgement matters.

CRS & HIPEC is not a procedure.
It is an ecosystem of decisions:
▪️ Patient selection
▪️ Operative planning
▪️ Peritonectomy planes
▪️ Massive resections
▪️ Workflow logistics
▪️ Complication management

And the uncomfortable truth?
Not every team doing HIPEC is truly equipped for the complexity it demands.
The gap between knowing and doing is where outcomes are won or lost.
This workshop is built for surgeons who want to close that gap — not with more slides, but with tissue planes, operative strategy, and cadaveric insight.
#CRS #HIPEC #SurgicalOncology #PeritonealSurfaceMalignancy #GynecologicOncology #CancerSurgery #OncoSurgery #CadavericWorkshop #Peritonectomy #MedicalEducation

@PSugarbaker @writeslkpushkin @glehenolivier @zeebausofi @MufaddalKazi @Snioncosurgeon1 @vivekanandkem @sukumar_vivek @Bhandoria

[INDEPSO @indepso]

“Complete cytoreduction” sounds elegant in presentations.
In reality, it’s anatomy under tension, difficult planes, bleeding control, fatigue, judgement, and knowing exactly when to push further.
CRS & HIPEC is among the most technically demanding procedures in surgical oncology — and mastering it requires more than conference lectures.
The Oncology Group of Pune conference aims to bridge that gap with hands-on cadaveric insight and operative discussions focused on real surgical challenges.
From theory to tissue. Literally.
#HIPEC #CRS #PeritonealMalignancy #SurgicalEducation #Oncology #GynecologicOncology #SurgicalSkills #CancerCare #OncoSurgery
@PSugarbaker @glehenolivier @zeebausofi @writeslkpushkin @vivekanandkem @sukumar_vivek @docswapnil01 @MufaddalKazi @Bhandoria

[INDEPSO @indepso]

Every centre wants to “start HIPEC.”
The better question is:
Is your team really doing an adequate CRS, dealing with the complexities of the resections it entails, and does it truly have a handle on the complications that follow?

Patient selection

Operative planning

Peritonectomy planes

Workflow logistics

Intraoperative surprises

Post-op course

The 3rd Biennial Conference of the Oncology Group of Pune is built around the realities of CRS & HIPEC — not just the glamour of it.
A serious workshop for surgeons serious about peritoneal surface malignancy.
#CRS #HIPEC #PeritonealSurfaceOncology #SurgicalOncology #GynecologicCancer #CancerSurgery #MedicalEducation #CadavericTraining #OncoSurgery

@PSugarbaker @glehenolivier @zeebausofi @writeslkpushkin @Snioncosurgeon1 @MufaddalKazi @docswapnil01 @vivekanandkem @sukumar_vivek

[Mufaddal Kazi @MufaddalKazi]

KSERS2026
Good to be back to Seoul after a couple of year with colleagues and Fellows
Met Mentors and overseas colleagues.
Presented our institutional work on Minimally invasive work in colorectal cancers @TataMemorial @ACTREC_TMC

[INDEPSO @indepso]

Most surgeons can describe CRS & HIPEC.
Far fewer can execute it consistently when anatomy is distorted, planes disappear, and every decision changes oncologic outcome.
That gap — between knowing and doing — is exactly what this workshop is built to address.
The 3rd Biennial Conference of the Oncology Group of Pune brings together focused cadaveric training, operative strategy, and real-world discussion in peritoneal surface malignancy and gynecologic oncology.
Because surgical precision is not theoretical.
It is practiced.
#CRS #HIPEC #SurgicalOncology #PeritonealSurfaceMalignancy #GynecologicOncology #CancerSurgery #OncoSurgery #MedicalEducation #CadavericWorkshop

@PSugarbaker @glehenolivier @writeslkpushkin @MufaddalKazi @zeebausofi @vivekanandkem @sukumar_vivek @Bhandoria @Snioncosurgeon1 @docswapnil01

[INDEPSO @indepso]

Announcing the 3rd Biennial Conference of the Oncology Group of Pune on Peritoneal Surface Malignancy & Gynecologic Oncology.
🗓 17–19 Sept 2026
📍 Pune
A focused meeting addressing the complexities and dilemmas in peritoneal surface oncology.

Highlights:
🔬 Pre-conference Cadaveric Workshop on Cytoreductive Surgery & Peritonectomy
🧠 Didactic lectures & panel discussions
🔎 Live pathology workshop
🌍 Stellar international & national faculty

Featuring renowned international experts including Prof. @PSugarbaker , Prof. @glehenolivier , Prof. Artem Stepanyan & Prof. Lana Bijelic.
Join us in Pune to exchange ideas, debate dilemmas, and advance care in peritoneal surface malignancy.

@writeslkpushkin @PSOGI_EC @IASO_IJSOonline @sukumar_vivek @MufaddalKazi @avanishsaklani @zeebausofi

#CRS #HIPEC #SurgicalOncology #GynecOnc #PeritonealSurfaceMalignancy

[INDEPSO @indepso]

CRS & HIPEC isn’t learned from slides.
It’s learned in the planes. In the bloodless dissections. In the decisions that separate “adequate” from truly complete cytoreduction.
The 3rd Biennial Conference of the Oncology Group of Pune is bringing surgical oncology out of theory and onto the table — with a focused cadaveric workshop designed for surgeons who want to sharpen operative precision, rethink peritoneal disease, and push the boundaries of CRS & HIPEC.
Questions we should all be asking:
▪️ Are we really optimizing cytoreduction?
▪️ Can our centres handle complex HIPEC workflows?
▪️ Are we prepared for the intraoperative challenges we pretend are “rare”?
▪️ How do we convert textbook knowledge into reproducible surgical excellence?
This is where theory meets tissue.

Register NOW!

@PSugarbaker @glehenolivier @PSOGI_EC @writeslkpushkin @vivekanandkem @sukumar_vivek @MufaddalKazi @Snioncosurgeon1 @zeebausofi @Bhandoria @docswapnil01
#CRS #HIPEC #PeritonealSurfaceMalignancy #GynecologicOncology #SurgicalOncology #OncoSurgery #CancerSurgery #PeritonealMalignancy #HIPECSurgery #MedicalEducation #CadavericWorkshop #OncologyGroupOfPuneCRS & #CadavericWorkshop #OncologyGroupOfPune

[BJS @BJSurgery]

Management of gastric cancer peritoneal metastasis: International Gastric Cancer Association GCPM Working Group consensus statements
➡️ https://t.co/no5ToPrJV5

This international IGCA consensus provides a global framework for managing gastric cancer peritoneal metastases, achieving agreement on 13 key statements across diagnosis, treatment, and research priorities. Ongoing uncertainty around optimal systemic therapy highlights the need for further evidence in this rapidly evolving field.

Work by Piers R Boshier, on behalf of the IGCA GCPM Working Group

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #some4UGI #uppergi #esophagealcancer #gastriccancer #reflux @ISDE_net @Augishealth @roux_group @T4UGIS @SARONG_Trial @YoungIFSO #bariatricsurgery

[Entisar saleh @Entisar_kilani]

ESMO guidelines for localized rectal cancer .

#ESMO #oncology #Hematology #medtwitter

[INDEPSO @indepso]

🚨 Join the ERAS Conversation in Peritoneal Surface Oncology 🚨

The Indian Network for Development of Peritoneal Surface Oncology (INDEPSO) brings you an insightful session in its Educational Series on Peritoneal Surface Malignancies:

🩺 ERAS PANEL DISCUSSION
(Enhanced Recovery After Surgery)

📅 Friday, 24th April
⏰ 8:00 – 9:00 PM (IST)
💻 Live on Zoom

This expert-led panel will explore evidence-based strategies to optimize perioperative care, enhance recovery, and improve outcomes in patients undergoing complex oncologic procedures.

🎙️ Moderator:
Dr Geetu Bhandoria (Command Hospital, Kolkata)

👨‍⚕️ Expert Panel:
• Prof M.D. Ray (AIIMS, New Delhi)
• Dr Jaiprakash Gurawalia (Fortis Hospital, Gurugram)
• Dr Rohit Kumar (Aster Hospitals, Bengaluru)
• Dr Deepti Mishra (Thangam Cancer Center, Namakkal & Kanpur)
• Dr Ambarish Chatterjee (Apollo Hospitals, Nashik)

💡 Expect a dynamic discussion covering:
✔️ ERAS protocols in peritoneal surface malignancies
✔️ Practical challenges in implementation
✔️ Multidisciplinary coordination
✔️ Real-world insights from high-volume centers

Whether you’re a surgical oncologist, anesthetist, resident, or part of the perioperative care team—this session offers valuable, practice-changing perspectives.

🔗 Don’t miss it — join the discussion and be part of the evolving ERAS paradigm.

#INDEPSO #ERAS #PeritonealSurfaceOncology #SurgicalOncology #CancerCare #EnhancedRecovery #MedicalEducation #OncologyCommunity

Join us live tomorrow night on zoom
Click to register: https://t.co/7zewKHfF6M

Meeting ID: 828 6843 0728
Passcode: 322511

@PSOGI_EC @PSugarbaker @writeslkpushkin @MufaddalKazi @Bhandoria

[Mufaddal Kazi @MufaddalKazi]

@PSOGI_EC Consensus on #MIS Cytoreduction for peritoneal metastasis in @BJSurgery
https://t.co/38SzD5PlBK
Glad to be part of this led by @alarjosan
@indepso @IspsmHipec @ISSPP1 @TataMemorial @ACTREC_TMC
@writeslkpushkin @somusp9 @DeliaCortesGuir @KurtSpeeten @glehenolivier

[Alvaro Arjona @alarjosan]

Very variable the "eye" of oncologic surgeons how to classify intraperitoneal lessions, more precise tools are needed to help us introperativelly, such as radiomics, antibodies and fluorescence, IO digit pathology, AI etc. More research is needed @indepso @PSOGI_EC @aecirujanos

[Alvaro Arjona @alarjosan]

Intersting work published about the variability interobserver when the peritoneal lessions are classified and define. Nice multicenter study published in @AnnSurgOncol by @writeslkpushkin and @glehenolivier @indepso @PSOGI_EC @cirugiacancer @aecirujanos
https://t.co/AiDK0Rhunh